Containing Or Obtained From Camellia (e.g., Tea, Including Green Or Black Tea, Etc.) Patents (Class 424/729)
-
Patent number: 8067043Abstract: A pharmaceutical or medicinal herbal composition and method of making the composition comprised of a mixture of the following herbal ingredients: Glycine max, Plumbago zeylanica, Terminalia arjuna, Trigonella-foenum-graceum, Coleus forskohlii, Commiphora mukul, Camellia sinensis, and Azadirachta indica.Type: GrantFiled: August 8, 2008Date of Patent: November 29, 2011Assignee: Sahajanand Biotech Pvt. Ltd.Inventor: Nandkishor Bapurao Managoli
-
Publication number: 20110287116Abstract: A formulation comprising jasmonate for improving cardiac muscle function, particularly by modulating myocardial contractility in a subject is disclosed. Such a formulation may be used to treat a heart or cardiac related disorder.Type: ApplicationFiled: May 18, 2011Publication date: November 24, 2011Applicant: BROADY HEALTH SCIENCES LLCInventor: Brunde Broady
-
Publication number: 20110280855Abstract: The field of invention relates to Vitamin C compositions, and in particular to Vitamin C compositions containing ascorbate-glucose transport enhancers. In at least one aspect, a composition is provided herein that includes ascorbate in an amount from about 0.1% by weight of actives to about 99.9% by weight of actives, and at least one ascorbate-glucose transport enhancer in an amount from about 0.01% by weight of actives to about 99.0% by weight of actives. In other aspects, methods of improving the transport of ascorbate into cells and tissues, and improving the ascorbate or antioxidant status of a person, are provided that include providing a composition comprising ascorbate and at least one ascorbate-glucose transport enhancer.Type: ApplicationFiled: June 3, 2011Publication date: November 17, 2011Inventor: Neil Levin
-
Publication number: 20110280851Abstract: Described herein are compositions that comprise cranberry extract and are potent and low in calories. Methods of preventing or treating infections by administering the described compositions are also provided.Type: ApplicationFiled: May 12, 2011Publication date: November 17, 2011Inventors: Alexander S. Herzlinger, Tina Shih-Ping Wu
-
Publication number: 20110274680Abstract: Synergistic chemical compositions of bioactive compounds in a dietary supplement for lowering the risks of Alzheimer's, Cardiovascular and Diabetes diseases; chemical compositions of a sugar free super sweetener for people with Type-2 Diabetes disease and a targeted nano delivery of bioactive compounds and/or bioactive molecules are described. Furthermore, microelectro-mechanical system (Mems) based passive and active (based on feedback diagnostics data) delivery systems and methods of bioactive compounds and/or bioactive molecules are also described.Type: ApplicationFiled: July 15, 2011Publication date: November 10, 2011Inventors: Mohammad A. Mazed, Sayeeda Mazed
-
Publication number: 20110274728Abstract: Various compositions and methods are provided to alleviate one or more symptoms associated with hyposalivation or xerostomia. Preferred compositions and methods employ one or more plant extracts and/or a proanthocyanidin at a concentration effective to reduce or eliminate the symptoms. Especially preferred extracts are isolated from a fruit and/or seed (e.g., grape, cranberry, blue berry, black berry, etc.), and where a second extract is present, such extract is preferably isolated from a citrus fruit (e.g., lemon, orange, lime, grapefruit, tangerine, mandarin orange, ugli fruit, etc.).Type: ApplicationFiled: November 13, 2009Publication date: November 10, 2011Inventors: David Hamlin, Satyanarayana Majeti, Zbigniew Pietrzkowski
-
Publication number: 20110268718Abstract: A method for producing a cactus fruit extract for use in formulating a beverage which can be used in the treatment of veisalgia.Type: ApplicationFiled: January 14, 2010Publication date: November 3, 2011Applicant: KAAHEE RESEARCH AND DEVELOPMENT GMBHInventor: Julian Rauchdobler
-
Publication number: 20110262553Abstract: Compositions comprising vitamin E, vitamin C, and white tea extract for treating cutaneous signs of aging are disclosed. The compositions reduce signs of wrinkles and improve other skin conditions, such as increased skin elasticity and skin softness. Moreover, the prevention or treatment of unhealthy skin, such as aged skin or skin overexposed to sunlight, may advantageously be accomplished by the administration of the compositions of the present invention. The compositions includes the combination of a number of different components, which interact to provide the desired improvements to the skin. Further advantageous ingredients of the compositions may comprise, naturally occurring antioxidants extracted from e.g. grape seeds and tomato, an extract comprising glycosaminoglycans, a transition metal component in an amount effective to bind collagen and elastic fibers and thicken skin, and a catechin-based component present in an amount sufficient to inhibit the presence of anti-collagen enzyme in the skin.Type: ApplicationFiled: June 24, 2005Publication date: October 27, 2011Applicant: FERROSAN A/SInventors: Annebeth Siø Jensen, Annette Strarup Kristensen, Henrik Enghusen Poulsen, Jana Vicanova, Nico Smit
-
Publication number: 20110262417Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.Type: ApplicationFiled: July 24, 2009Publication date: October 27, 2011Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.Inventors: Franco Gaetani, Ashraf Virmani
-
Patent number: 8043635Abstract: The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant.Type: GrantFiled: December 15, 2008Date of Patent: October 25, 2011Assignee: Akzo Nobel Surface Chemistry LLCInventor: Michael Koganov
-
Publication number: 20110256247Abstract: Activated fatty acids, topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases.Type: ApplicationFiled: June 30, 2011Publication date: October 20, 2011Applicant: NITROMEGA CORP.Inventor: Raymond A. Miller
-
Publication number: 20110256248Abstract: The present invention provides a performance assay that measures the total antioxidant activity of a composition using oxygen uptake in contrast to prior art methods that measure antioxidant capacity by indirectly measuring degradation of a fluorescent compound by following the disappearance of fluorescence. Using the performance antioxidant assay of the present invention, an antioxidant composition having synergistic activity is provided by the present inventors that includes flavonoids such as the flavonol quercetin, mixed tocopherols or tocotrienols, grape skin extract, green tea extract and bush plum. The antioxidant activity of the present composition exceeds 6,000 micromoles Trolox equivalent units per gram using the present invention.Type: ApplicationFiled: June 28, 2011Publication date: October 20, 2011Applicant: MANNATECH, INCORPORATEDInventors: Bill H. McAnalley, Eileen Vennum, Shayne A. McAnalley, C. Michael Koepke
-
Patent number: 8039012Abstract: A pharmaceutical composition for treatment of skin aging including a pharmaceutically effective amount of estriol; a pharmaceutically effective amount of estradiol; a pharmaceutically effective amount of hyaluronic acid; a pharmaceutically effective amount of green tea extract; and a pharmaceutically acceptable carrier is provided. In some embodiments, the composition further includes ascorbic acid, date palm extract, or a combination thereof. Also disclosed is a method for treating symptoms of skin aging and photoaging by administering a pharmaceutical composition having estriol, estradiol, hyaluronic acid, green tea extract, a pharmaceutically acceptable carrier and optionally, ascorbic acid and date palm extract. A method of promoting urogenital function is likewise provided wherein a pharmaceutical composition having estriol, estradiol, hyaluronic acid, and green tea extract is applied intravaginally.Type: GrantFiled: July 7, 2010Date of Patent: October 18, 2011Assignee: McKA, LLCInventors: Stephanie N. McClellan, Ashton A. Kaidi
-
Publication number: 20110250299Abstract: The present invention is directed towards organogel compositions comprising a phospholipid composition. Processes for producing such organogel compositions are further disclosed. The present invention is also directed towards uses of the novel organogel compositions in foods or beverages, cosmetics, personal care products, as a drug delivery vehicle or as a carrier of any desired compound.Type: ApplicationFiled: November 13, 2009Publication date: October 13, 2011Applicant: ARCHER DANIELS MIDLAND COMPANYInventors: Shireen S. Baseeth, Bruce R. Sebree
-
Publication number: 20110243985Abstract: Disclosed is a self-adhesive matrix system comprising a styrene-ethylene/butylene-styrene (SEBS) copolymer in an oil/ethyl acetate mixture, a hydrogenated resin and a pharmaceutical or cosmetic active ingredient.Type: ApplicationFiled: December 10, 2009Publication date: October 6, 2011Inventors: Stefania Pagani, Maurizio Di Grigoli, Sergio Comuzio
-
Publication number: 20110244061Abstract: The invention provides methods for increasing resting metabolic rate, reducing waist circumference, and weight control by administering a composition comprising dietary fiber, phenylalanine, tyrosine, tea blend, caffeine, and Lycium plants or Lycium plant extract preparations to the subject. The invention also provides a food or dietary supplement formulation which contains dietary fiber, phenylalanine, tyrosine, tea blend, caffeine, and Lycium plants or Lycium plant extract preparations.Type: ApplicationFiled: February 5, 2009Publication date: October 6, 2011Inventors: Harunobu Amagase, Richard Handel
-
Patent number: 8029830Abstract: The present invention relates to a new composition comprising substances that promote DNA repair, reduce body fat levels and increase lean body mass and that decrease wrinkle appearance and/or improvement in skin surface. In some aspects, the composition of the present invention include resveratrol, forskohlin and astaxanthin. In another aspect the composition of the present invention further comprises carboxy alkyl ester. The present invention also relates to a method of promoting internal health and external appearance in a subject in need, said method comprising administering to the subject a composition that promotes DNA repair, reduces body fat levels and increases lean body mass and that decreases wrinkle appearance and/or improvement in skin surface.Type: GrantFiled: January 8, 2009Date of Patent: October 4, 2011Assignee: Nuvocare Health Services Inc.Inventor: Ryan Jason Foley
-
Publication number: 20110236510Abstract: Pregnane glycoside or a Caralluma extract including the pregnane glycoside of the present invention can be used for medical purposes and as food additives, such as a treatment of obesity, a reduction of blood glucose, a reduction of blood pressure, a reduction in hip, waist and arm circumferences, a reduction of fat, increase of BMR, a decrease of BMI, an increase of lean body mass, an appetite-suppression and a reduction/elimination of joint pain, anti-aging, a treatment for falling sex drive, the treatment for impotency and an erectile dysfunction, and an enhancement of energy levels.Type: ApplicationFiled: June 6, 2011Publication date: September 29, 2011Inventors: RAMASWAMY RAJENDRAN, KAMALA RAJENDRAN
-
Publication number: 20110230816Abstract: The present disclosure provides hydrogels that are suitable for drug delivery. In embodiments, hydrogels of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The hydrogels of the present disclosure may also be useful as conductive compositions for use with electrodes.Type: ApplicationFiled: August 31, 2010Publication date: September 22, 2011Applicant: TYCO HEALTHCARE GROUP LPInventor: Warren Copp-Howland
-
Publication number: 20110217392Abstract: This invention provides a composition and method for countering the effects of alcohol consumption by a person. The composition provided is a specifically proportion combination of various vitamins, potassium, magnesium, milk thistle extract, amino acids, green tea extract, prickly pear extract, malic acid, and optionally Maqui berry extract, and various other additives for flavor and preservatives for a liquid formulation. The method includes orally administering the composition to a person under the influence of alcohol.Type: ApplicationFiled: March 1, 2011Publication date: September 8, 2011Applicant: LIQUID INNOVATIONS, LLCInventors: Cason Thorsby, Curtis Thorsby
-
Publication number: 20110206747Abstract: The present invention relates to a composition inhibiting or destroying at least one living or unicellular organism, which comprises at least one anti-infectious agent and at least one activating agent containing at least one metal element, together with at least one dispersing agent. The present invention also relates to the utilization of such a composition.Type: ApplicationFiled: May 19, 2010Publication date: August 25, 2011Inventors: Pierre LAGNY, Jean-Jacques HERAULT
-
Publication number: 20110200689Abstract: The inventive subject matter relates to methods for treating glioblastoma, comprising administration of a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis, rosemary, green tea, huzhang, Chinese goldthread, and barberry. The inventive subject matter further relates to methods for modulating gene expression of genes selected from the group consisting of interleukin-1?, interleukin-1?, heme oxygenase 1, aldo-keto reductase family 1, member C2, colony stimulating factor 3, leukemia inhibitory factor, heat shock 70 kDa protein, and combinations thereof, by administration of an effective amount of said compositions.Type: ApplicationFiled: March 24, 2011Publication date: August 18, 2011Applicants: NEW CHAPTER INC., THE CLEVELAND CLINIC FOUNDATIONInventors: Thomas NEWMARK, Mladen GOLUBIC, Paul SCHULICK
-
Patent number: 7999003Abstract: The present invention provides a performance assay that measures the total antioxidant activity of a composition using oxygen uptake in contrast to prior art methods that measure antioxidant capacity by indirectly measuring degradation of a fluorescent compound by following the disappearance of fluorescence. Using the performance antioxidant assay of the present invention, an antioxidant composition having synergistic activity is provided by the present inventors that includes flavonoids such as the flavonol quercetin, mixed tocopherols or tocotrienols, grape skin extract, green tea extract and bush plum. The antioxidant activity of the present composition exceeds 6,000 micromoles Trolox equivalent units per gram using the present invention.Type: GrantFiled: August 26, 2003Date of Patent: August 16, 2011Assignee: Mannatech, IncorporatedInventors: Bill H. McAnalley, Eileen Vennum, Shayne A. McAnalley, C. Michael Koepke
-
Patent number: 7998507Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.Type: GrantFiled: December 7, 2005Date of Patent: August 16, 2011Assignee: Elan Pharma International Ltd.Inventors: H. William Bosch, Greta G. Cary, Douglas C. Hovey, Rajeev A. Jain, Laura J. Kline, Elaine Merisko-Liversidge, Kevin D. Ostrander, Niels P. Ryde, Stephen B. Ruddy
-
Publication number: 20110195039Abstract: A method of treating hair comprising applying a hair building solid agent for use on or with one or more of hair, skin and hair building solids for altering and/or maintaining the electrostatic charge of the hair and/or skin such that it has a substantially negative polarity. The method further comprises applying hair building solids to hair before and/or during and/or after applying the hair building solid agent. The hair building solid agent is applied as a spray on to the hair and/or skin and/or hair building solid.Type: ApplicationFiled: February 11, 2011Publication date: August 11, 2011Applicant: PANGAEA LABORATORIES LTD.Inventor: Elliot Isaacs
-
Publication number: 20110189316Abstract: The present application describes a composition for blood glucose control containing green tea extracts (GTE) with gallated catechins (GC) and macromolecule to prevent the intestinal absorption of GC.Type: ApplicationFiled: July 23, 2009Publication date: August 4, 2011Applicants: Keimyung University Industry Academic Cooperation Foundation, Dae-Kyu SONGInventors: Dae-Kyu Song, Jinho Lee
-
Patent number: 7989009Abstract: A composition for promoting weight loss comprising black tea extract, white tea extract, oolong tea extract, guarana extract, green maté extract, thiamine, choline and N-acetylcysteine. The composition may be administered in methods for promoting weight loss by increasing fat oxidation and/or controlling appetite.Type: GrantFiled: February 2, 2006Date of Patent: August 2, 2011Assignee: Advocare International, L.P.Inventors: Chithan Kandaswami, Sidney Stohs, Christina Coyle
-
Patent number: 7989007Abstract: The present invention comprises a purposefully formulated weight loss composition and a method for causing a meaningful weight loss in a living human subject. The formulated weight loss composition, in its most preferred embodiments comprises: at least one amino acid that is a pharmacologically active precursor in the catecholamine biosynthesis pathway; one or more sympathomimetic agents; a lipolytic agent; a high-Dalton macromolecular protein, and a plurality of micronutrients. The preferred composition is formulated as a dry particulate admixture initially; and then is made into a fluid beverage, which is able to achieve multiple physiologic functions in-vivo. These in-vivo functions include: causing a meaningful weight loss, with a preference for lipolysis and fat metabolism; providing for a low glycemic index; offering lean muscle maintenance and replenishment; and concomitantly initiating dopaminergic (D2-receptor) brain stimulation, resulting in improved cognitive function and affective augmentation.Type: GrantFiled: May 13, 2008Date of Patent: August 2, 2011Assignee: Vincent James Enterprises, LLCInventors: Vincent Giuliano, James Manley
-
Patent number: 7981449Abstract: Provided is a process for producing a purified green tea extract of high quality by readily and efficiently purifying a green tea extract in a simple manner. A process for producing a purified product of green tea extract, which includes subjecting an aqueous solution of green tea extract to solid-liquid separation by filtration and/or centrifugal separation to obtain another aqueous solution of green tea extract, said another aqueous solution having a turbidity of from 0.2 to 2.0 as measured with a concentration of non-polymer catechins in it adjusted to 1 wt %, and then allowing the another aqueous solution of green tea extract to pass through a polymer membrane having a membrane pore size of from 0.05 to 0.8 ?m such that the turbidity of the another aqueous solution of green tea extract is reduced to lower than 0.2 as measured with a concentration of non-polymer catechins in it adjusted to 1 wt %.Type: GrantFiled: May 16, 2006Date of Patent: July 19, 2011Assignee: Kao CorporationInventors: Yukiteru Sugiyama, Hideaki Ueoka
-
Publication number: 20110171328Abstract: The invention discloses a pharmaceutical composition for synergistically treating and preventing diabetic complication. The composition contains 1-deoxynojirimycin and fagomine, and the weight ration of the 1-deoxynojirimycin to the fagomine is 0.5-5:1.Type: ApplicationFiled: August 11, 2008Publication date: July 14, 2011Inventors: Yingjun Zhou, Guangrao Zeng, Meixiang Jiang
-
Patent number: 7976880Abstract: Pregnane glycoside or a Caralluma extract including the pregnane glycoside of the present invention can be used for medical purposes and as food additives, such as a treatment of obesity, a reduction of blood glucose, a reduction of blood pressure, a reduction in hip, waist and arm circumferences, a reduction of fat, increase of BMR, a decrease of BMI, an increase of lean body mass, an appetite-suppression and a reduction/elimination of joint pain, anti-aging, a treatment for falling sex drive, the treatment for impotency and an erectile dysfunction, and an enhancement of energy levels.Type: GrantFiled: April 26, 2005Date of Patent: July 12, 2011Inventors: Ramaswamy Rajendran, Kamala Rajendran
-
Patent number: 7976879Abstract: A product and method for administering daily micronutrient requirements (DMRs) comprising vitamins, minerals and essential fatty acids targeted to reduce appetite and/or the risks associated with aging and associated cognitive impairment. The DMRs are administered to individuals via food products. In an embodiment of the present invention, the DMRs are offered in the form of a health bar, smoothie, or drink. The DMRs may be incorporated into other forms without departing from the scope of the present invention. By way of illustration and not as a limitation, the constituents may be incorporated into a fruit or yogurt “smoothie,” a frozen desert such as an ice cream or sorbet, and a beverage.Type: GrantFiled: July 23, 2009Date of Patent: July 12, 2011Inventor: Michael F. Roizen
-
Publication number: 20110159121Abstract: Provided herein are methods of culturing cells in vitro in order to exploit the biochemical production ability of the cells to make metabolites that are evaluated and harvested for their biological effects. Also provided are systems for evaluating extracts from such cultured cells to characterize their biological activity(s), particularly with regard to impact on health, wellbeing, longevity, DNA maintenance, mitochondrial health and/or biogenesis, and so forth. Biologically active extracts, components thereof, and compositions (such as cosmetic or pharmaceutical preparations) made comprising such, are also provided.Type: ApplicationFiled: December 22, 2010Publication date: June 30, 2011Inventor: David H. McDaniel
-
Publication number: 20110159122Abstract: The present invention relates to combinations of extracts of various plants. A plant extract is obtained from unfermented rooibos by extraction with a mixture of water and alcohol. The rooibos extract contains a compound of formula I (aspacat). The compound of formula I is shown below: The extracts of other plants are obtained from fermented rooibos and/or green tea and/or curcuma and/or ginseng. The combinations can be used as drugs and/or food supplements for the prevention and/or treatment of dementia disorders.Type: ApplicationFiled: August 11, 2009Publication date: June 30, 2011Applicant: Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & Co,KGInventor: Bruno Frank
-
Publication number: 20110158932Abstract: Methods and compositions containing a berberine compound or berberine related or derivative compound are provided for the prevention and treatment of hyperlipidemia, elevated cholesterol, and/or cardiovascular disease in mammalian subjects. The methods and compositions of the invention are effective for prevention and treatment of atherosclerosis, coronary artery disease, angina pectoris, carotid artery disease, stroke, cerebral arteriosclerosis, high blood pressure, myocardial infarction, cerebral infarction, restenosis following balloon angioplasty, intermittent claudication, dyslipidemia post-prandial lipidemia or xanthoma.Type: ApplicationFiled: December 8, 2008Publication date: June 30, 2011Inventors: Jian-Dong Jiang, Jing Wei, Wei-Jia Kong, Li-Xun Zhao, Dan-Qing Song
-
Publication number: 20110151009Abstract: The present invention relates to the use of one or more free radical scavengers as prophylactically or therapeutically effective substances and microparticles having an average particle size ranging from 5 to 200 ?m for the preparation of a topical pharmaceutical composition for the protection or treatment of skin or hair damages caused by chemotherapeutic treatment. The invention also concerns a method for the protection or treatment of skin and hair damages of a mammal caused by chemotherapy. The invention further relates to a kit for the protection or treatment of hair damages caused by chemotherapeutic treatment consisting of a topical composition comprising microparticles together with free radical scavengers and a shampoo for an effective hair cleaning and supporting the hair treatment.Type: ApplicationFiled: February 25, 2011Publication date: June 23, 2011Inventors: Karin Golz-Berner, Leonhard Zastrow
-
Publication number: 20110135681Abstract: A new treatment for individuals suffering from type 2 diabetes. The formulation used in the treatment includes a mixture of a thiazoleineione, an insulin, cinnamon bark extract, and at least one synergistic supplement selected from the group consisting of blueberry leaf extract, cranberry extract, kelp extract, sugar sea beet extract, acerola berry extract; ginger root extract, black cherry extract, green tea extract, Irish moss extract, aloe vera extract, and Stevia leaf extract. The thiazoleineione is preferably pioglitazone. The insulin is preferably an Insulin Aspart of rDNA origin. It is preferred that the cinnamon bark extract and synergistic supplement be in the form of a liquid concentrate.Type: ApplicationFiled: December 3, 2010Publication date: June 9, 2011Inventor: Curtis C. Stojan
-
Publication number: 20110135759Abstract: Compositions of matter, uses, and formulations of food supplements/nutrients capable of eliciting mobilization of various stem/progenitor cells, including hematopoietic stem cells and endothelial progenitor cells are disclosed. In one embodiment a formulation contains a mixture of ellagic acid, vitamin D3, beta 1,3 glucan and a ferment of the bacterium, Lactobacillus fermentum, with an extract of green tea, extract of goji berries, and extract of the root of astragalus added prior to fermentation. Said formulation, originally developed as an antioxidant/immune stimulator was found to have the unexpected property of eliciting stem/progenitor cell mobilization.Type: ApplicationFiled: December 9, 2010Publication date: June 9, 2011Applicant: Aidan Products, IncInventor: Neil H. Riordan
-
Publication number: 20110135708Abstract: A new chewing gum comprising a gum member, with a central core or cavity, and a core element located within the central core or cavity. The chewing gum also comprises a dietary supplement, which may be incorporated in the central core, the cavity, or both. The core element can be of a range of consistencies, from fluid to gel-like. Optionally, the gum member may comprise crystals. Additionally, the crystals may comprise a dietary supplement. The chewing gum may be encapsulated with a coating. Multiple dietary supplements, of different or of the same varieties, may be incorporated into the chewing gum.Type: ApplicationFiled: December 7, 2010Publication date: June 9, 2011Inventor: Brent Holland
-
Patent number: 7955624Abstract: A composition and method for promoting weight loss through the mutual and simultaneously to promotion lipolysis, the expenditure of energy stored in the body as fat, the inhibition of lipolysis as well as affording the body of an individual protection from reactive oxygen species resulting from the ?-oxidation of fats. The composition comprises at least a lipolytic substance, a thermogenic substance, a substance to inhibit the reformation of triglycerides in the bodily tissues of an individual and an antioxidant.Type: GrantFiled: November 14, 2007Date of Patent: June 7, 2011Assignee: HHC Formulations Ltd.Inventors: Marvin A. Heuer, Ken Clement
-
Patent number: 7956067Abstract: Novel compositions comprising a combination of at least one higher primary aliphatic alcohol preferably selected from those having 18 to 40 carbon atoms or mixtures thereof, at least one source of 5-hydroxytryptophan (5-HTP) optionally additionally comprising a source of caffeine and/or catechin-polyphenol and/or epigallocatechin gallate as active agents, either alone or in combination with other active agent(s), optionally with one or more excipient(s) are provided. Particularly, the invention relates to compositions and process for preparation of such compositions and method of use thereof for the management of obesity and associated disorders.Type: GrantFiled: May 9, 2007Date of Patent: June 7, 2011Assignee: Panacea Biotec LimitedInventors: Rajesh Jain, Kour Chand Jindal
-
Publication number: 20110129546Abstract: The invention relates to a dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis and pruritus. The invention comprises a base anti-inflammatory agent, such as indometacin; one or more optional active ingredients selected alternatively from among at least a corticoid and an antibiotic; and a combination of topical antioxidants used to potentiate the anti-inflammatory effect, selected from among green tea, lipoic acid, curcumin, ascorbyl palmitate, Coenzyme Q10, resveratrol, Pycnogenol™, L-camosine, taurine, vitamin E, vitamin C, papaya extract, isoflavones, manganese, lycopene and quercetin. At least one of the topical antioxidants is a peroxisome proliferator-activated receptor-gamma (PPAR-?) activator. The invention also includes at least one antioxidant substance with an antiproliferative effect on keratonocytes, e.g.Type: ApplicationFiled: June 19, 2009Publication date: June 2, 2011Inventor: Ignacio Umbert Mill
-
Publication number: 20110129543Abstract: The present application concerns plant extracts which have been fermented with kephir grains, methods of production of these extracts, a powder comprising these extracts and compositions comprising these extracts. Since these extracts have a high content of aglycone active principles, their biological activities are high and their applications are varied.Type: ApplicationFiled: June 15, 2007Publication date: June 2, 2011Applicant: KEFIPLANT INC.Inventors: Serge Rollan, Chantale Houle, Christian Deshayes
-
Publication number: 20110123650Abstract: It is intended to provide a cleansing cosmetic composition that quickly removes makeup from the skin, is easily applicable onto the skin without dripping from the hand or running on the face during application, and can freshen the skin because of being washed off thoroughly. The present invention provides a cleansing cosmetic composition comprising (1) 1 to 15% by mass of silicone oil, (2) 1 to 15% by mass of volatile hydrocarbon oil, (3) 5 to 20% by mass of dihydric glycol, (4) 5 to 40% by mass of polyoxyethylene glyceryl fatty acid ester, and (5) 15 to 88% by mass of water, wherein the weight ratio between the silicone oil (1) and the volatile hydrocarbon oil (2) ((1)/(2)) falls within the range of 0.3 to 3 and the composition has a viscosity of 100 to 500 mPas at 25° C.Type: ApplicationFiled: June 16, 2009Publication date: May 26, 2011Inventor: Tomohiko Kimura
-
Publication number: 20110117220Abstract: The present invention relates to a method of preparing a plant extract using a high-pressure enzymatic decomposition technique (HPED technique) and to a cosmetic composition containing the prepared plant extract as an active ingredient. The plant extract prepared using the high-pressure enzymatic decomposition technique developed according to the present invention contains various kinds and large amounts of effective components compared to extracts prepared using other extraction techniques, such that the effects of the effective components can be maximized.Type: ApplicationFiled: November 12, 2010Publication date: May 19, 2011Applicant: AMOREPACIFIC CORPORATIONInventors: Hyun Seo Kang, Hye Won Kim, Chan Koo Kang, Sung A. Cho, Jun Cheol Cho, Sang Hoon Han
-
Publication number: 20110117219Abstract: The invention relates to ether guanidines of the general formulae (I) and/or salts or hydrates thereof, in which R1=—CH2—CH2—CH2—O—R3 where R3 is, independently of the others, hydrocarbon radicals having greater than or equal to 10 carbon atoms, where part of the ether guanidines has radicals R3 which are branched and part of the ether guanidines has radicals R3 which are unbranched, and R2=independently of the others H or an optionally branched, optionally double-bond-containing hydrocarbon radical having 1 to 30 carbon atoms, and use thereof in hair treatment compositions and hair aftertreatment compositions, in particular for preventing damage by chemical treatment compositions and for repairing hair which is already damaged.Type: ApplicationFiled: May 28, 2009Publication date: May 19, 2011Applicant: EVONIK GOLDSCHMIDT GMBHInventors: Oliver Springer, Peter Muss, Burghard Gruening, Ursula Maczkiewitz, Mike Farwick, Peter Lersch
-
Publication number: 20110104251Abstract: The present invention comprises cosmetic compositions and methods for retarding hair growth comprising a combination of an ornithine decarboxylase inhibitor, an anti-angiogenic active and an anti-inflammatory.Type: ApplicationFiled: May 25, 2010Publication date: May 5, 2011Inventors: Mindy S. Goldstein, Chia Wen Chen, Christina G. Fthenakis, Kenneth D. Marenus, Thomas Mammone
-
Patent number: 7935367Abstract: A composition and method for promoting weight loss through the mutual and simultaneously to promotion lipolysis, the expenditure of energy stored in the body as fat, the inhibition of lipolysis as well as affording the body of an individual protection from reactive oxygen species resulting from the ?-oxidation of fats. The composition comprises at least a lipolytic substance, a thermogenic substance, a substance to inhibit the reformation of triglycerides in the bodily tissues of an individual and an antioxidant.Type: GrantFiled: March 8, 2007Date of Patent: May 3, 2011Assignee: HHC Formulations Ltd.Inventors: Marvin Heuer, Ken Clement, Shan Chaudhuri
-
Patent number: 7931922Abstract: The inventive subject matter relates to methods for treating glioblastoma, comprising administration of a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis, rosemary, green tea, huzhang, Chinese goldthread, and barberry. The inventive subject matter further relates to methods for modulating gene expression of genes selected from the group consisting of interleukin-1?, interleukin-1?, heme oxygenase 1, aldo-keto reductase family 1, member C2, colony stimulating factor 3, leukemia inhibitory factor, heat shock 70 kDa protein, and combinations thereof, by administration of an effective amount of said compositions.Type: GrantFiled: November 20, 2009Date of Patent: April 26, 2011Assignees: New Chapter Inc., The Cleveland Clinic FoundationInventors: Thomas Newmark, Mladen Golubic, Paul Schulick
-
Patent number: 7927633Abstract: A natural adaptogenic tea is prepared from adaptogens to counter adverse physical, chemical, or biological stressors and to promote t-cell activity and k-cell activity. Also, the composition is high in antioxidants and discourages free radicals. Moreover, the composition improves liver performance, resulting in improved toxin removal and improved nutrient absorption. In addition to these benefits, the composition improves capillary dilation, thereby providing better oxygenation to the brain. The tea is prepared from adaptogens including rhodiola, ashwagandha, schizandra berry, eleuthero and astralagus. Also, the tea includes damiana leaf, passion flower, milk thistle, white willow bark, goji berry, mangosteen, pomegranate, green tea, and sarsaparilla.Type: GrantFiled: March 28, 2008Date of Patent: April 19, 2011Inventor: Janiece Diane Swilling